Mental-Care & Nootropic Ingredients Market by Ingredient Type (Botanical Extracts/Adaptogens, Amino Acids, Vitamins & Minerals, Synthetic Nootropics), Function (Stress/Anxiety Relief, Mood Enhancement, Cognitive Performance, Application, and Distribution
Description
Mental-Care & Nootropic Ingredients Market Size, Share, Trends, Growth Opportunities & Forecast by Ingredient Type (Botanical Extracts/Adaptogens, Amino Acids, Vitamins & Minerals, Synthetic Nootropics), Function, Application, Distribution Channel, and Region – Global Forecast (2025 -2035)
According to the research report titled, 'Mental-Care & Nootropic Ingredients Market Size, Share, Trends, Growth Opportunities & Forecast by Ingredient Type (Botanical Extracts/Adaptogens, Amino Acids, Vitamins & Minerals, Synthetic Nootropics), Function, Application, Distribution Channel, and Region – Global Forecast (2025 -2035)' the mental-care and nootropic ingredients market is projected to reach $12.72 billion by 2035, at a CAGR of 9.6% during the forecast period 2025–2035. The report provides an in-depth analysis of the global mental-care and nootropic ingredients market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2035.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The growth of this market is driven by the rising prevalence of mental health disorders and stress-related conditions, increasing consumer awareness of cognitive health and preventive mental wellness, growing demand for natural and plant-based solutions, expanding clinical validation and regulatory acceptance of mental wellness claims, and the rising integration of nootropic ingredients into functional beverages and foods. Moreover, advancements in gut-brain axis research and psychobiotic innovation, functional beverage expansion and nootropic coffee alternatives, and personalized nutrition approaches for cognitive health are expected to support the market's growth.
The key players operating in the mental-care and nootropic ingredients market are Sabinsa Corporation (USA), Arjuna Natural Pvt. Ltd. (India), Ixoreal Biomed Inc. (India), Natreon Inc. (USA), Kyowa Hakko Bio Co. Ltd. (Japan), DSM-Firmenich (Switzerland), Chr. Hansen Holding A/S - Novonesis (Denmark), Glanbia Nutritionals (Ireland), Verdure Sciences (USA), Nexira (France), Nammex (Canada), and others.
The mental-care and nootropic ingredients market is segmented by ingredient type (botanical extracts/adaptogens, amino acids, vitamins and minerals, omega-3s and lipids, probiotics and microbiome-based ingredients, synthetic nootropics, and others), function (stress and anxiety relief, mood enhancement and emotional well-being, cognitive performance, neuroprotection and brain health, sleep and recovery, and energy and mental fatigue), application (dietary supplements, functional foods and beverages, personal care or nutraceutical cosmetics, pharmaceuticals for clinical mental health use, sports nutrition, and others), distribution channel (direct sales to manufacturers, distributors and ingredient brokers, online B2B platforms, and others), and geography. The study also evaluates industry competitors and analyzes the market at the country level.
Based on ingredient type, the botanical extracts and adaptogens segment held the largest share of the mental care and nootropic ingredients market in 2025. This dominance comes from the growing consumer preference for natural and plant-based options for managing stress, improving cognitive function, and enhancing emotional well-being. Scientific support for traditional adaptogenic herbs like ashwagandha, rhodiola, ginseng, and lion's mane mushroom, along with the rising popularity of Ayurvedic and traditional medicine worldwide, also fuels this segment's growth. The clean-label trend and consumer preference for botanical ingredients over synthetic ones continue to increase demand. Ashwagandha makes up a significant portion of the adaptogenic ingredients market, with India producing about 85% of the global supply from over 14,000 hectares. These botanical ingredients provide proven benefits for stress management, cognitive improvement, and emotional balance, backed by both traditional use and modern clinical research. The growth of this segment reflects a major shift in consumer attitudes toward mental wellness, favoring natural, holistic solutions over pharmaceutical options.
Regarding function, the stress and anxiety relief segment held the largest share of the mental care and nootropic ingredients market in 2025. This dominance reflects the widespread effects of chronic stress on modern populations and the growing preference for natural, non-drug options for stress management. The World Health Organization reported that the COVID-19 pandemic caused a 25% increase in anxiety and depression cases worldwide, which significantly raised consumer interest in natural mental wellness solutions. Ingredients like ashwagandha, rhodiola rosea, L-theanine, GABA, and magnesium are commonly used in this segment. Clinical studies show they can help regulate cortisol levels and support healthy stress responses. The normalization of mental health discussions, driven by public health campaigns and celebrity advocacy, has lessened the stigma around stress management products. Modern lifestyle factors such as workplace pressures, academic demands, digital overload, and constant connectivity contribute to higher stress levels in all demographics. Consumers increasingly seek ingredients that provide calm without sedation, reduce anxiety with no side effects, and support emotional resilience during tough times.
In terms of application, the dietary supplements segment accounted for the largest share of the mental care and nootropic ingredients market in 2025. This dominance comes from the established supplement industry, high consumer awareness of cognitive health benefits, and the growing preference for easy-to-use, encapsulated formats that provide accurate dosing and standardized ingredient concentrations. The global dietary supplements market reached $133.77 billion in 2024 and is projected to grow at a rate of 4.9% each year through 2032, with brain health supplements being one of the fastest-growing categories. The increasing occurrence of cognitive health issues globally, especially among older populations aiming to maintain mental sharpness and prevent age-related cognitive decline, continues to drive demand. Supplement formats offer several benefits, including concentrated ingredient doses, precise standardization, convenience, long shelf life, and the ability to combine multiple synergistic ingredients in one formulation. The segment benefits from well-established distribution networks, including pharmacies, health food stores, e-commerce platforms, and direct-to-consumer sales. Consumer trust in supplement brands, supported by third-party testing, quality certifications, and clear labeling, further boosts market growth.
For distribution channels, the direct sales to manufacturers segment held the largest share of the mental care and nootropic ingredients market in 2025. This segment’s dominance stems from the reduction of intermediary costs, the ability to provide customized ingredient solutions that meet specific manufacturer needs, and the established relationships between major ingredient suppliers and large nutraceutical and pharmaceutical companies. The direct sales model offers significant benefits in customization and technical support, with ingredient suppliers collaborating directly with manufacturers to deliver tailored solutions, including custom particle sizes, specialized extraction methods, proprietary blends, and application-specific standardization levels. This channel fosters close cooperation on product development, allowing ingredient suppliers to understand manufacturers’ needs and provide formulation support, regulatory documentation, quality assurance, and technical expertise. Major dietary supplement manufacturers, functional food producers, and pharmaceutical firms prefer direct relationships with ingredient suppliers to ensure supply chain security, maintain quality control, access technical innovation, and negotiate better pricing. The direct sales model promotes transparency throughout the supply chain, from raw material sourcing to final ingredient delivery, which is increasingly essential for manufacturers responding to clean-label requirements.
A detailed geographic analysis of the industry provides both qualitative and quantitative insights into five major regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa, alongside key countries in each region. North America commanded the largest share of the overall mental care and nootropic ingredients market in 2025. This result is tied to high consumer awareness regarding cognitive health, a strong wellness culture, the presence of major market players, supportive regulations that ease product development and market access, and high consumer spending power. The United States leads the global nootropics market, supported by a robust health and wellness sector where around 60% of adults take dietary supplements. The region's well-developed retail infrastructure includes both physical stores with dedicated nootropic sections and sophisticated e-commerce platforms, ensuring a wide range of products are available across diverse demographic groups. North America's active biohacking culture and growing interest in cognitive enhancement among students, professionals, and entrepreneurs have expanded the consumer base beyond traditional supplement users. The region also benefits from advanced research institutions, clinical trial setups, and regulatory pathways that support ingredient innovation and product development.
Key Questions Answered in the Report–
According to the research report titled, 'Mental-Care & Nootropic Ingredients Market Size, Share, Trends, Growth Opportunities & Forecast by Ingredient Type (Botanical Extracts/Adaptogens, Amino Acids, Vitamins & Minerals, Synthetic Nootropics), Function, Application, Distribution Channel, and Region – Global Forecast (2025 -2035)' the mental-care and nootropic ingredients market is projected to reach $12.72 billion by 2035, at a CAGR of 9.6% during the forecast period 2025–2035. The report provides an in-depth analysis of the global mental-care and nootropic ingredients market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2035.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The growth of this market is driven by the rising prevalence of mental health disorders and stress-related conditions, increasing consumer awareness of cognitive health and preventive mental wellness, growing demand for natural and plant-based solutions, expanding clinical validation and regulatory acceptance of mental wellness claims, and the rising integration of nootropic ingredients into functional beverages and foods. Moreover, advancements in gut-brain axis research and psychobiotic innovation, functional beverage expansion and nootropic coffee alternatives, and personalized nutrition approaches for cognitive health are expected to support the market's growth.
The key players operating in the mental-care and nootropic ingredients market are Sabinsa Corporation (USA), Arjuna Natural Pvt. Ltd. (India), Ixoreal Biomed Inc. (India), Natreon Inc. (USA), Kyowa Hakko Bio Co. Ltd. (Japan), DSM-Firmenich (Switzerland), Chr. Hansen Holding A/S - Novonesis (Denmark), Glanbia Nutritionals (Ireland), Verdure Sciences (USA), Nexira (France), Nammex (Canada), and others.
The mental-care and nootropic ingredients market is segmented by ingredient type (botanical extracts/adaptogens, amino acids, vitamins and minerals, omega-3s and lipids, probiotics and microbiome-based ingredients, synthetic nootropics, and others), function (stress and anxiety relief, mood enhancement and emotional well-being, cognitive performance, neuroprotection and brain health, sleep and recovery, and energy and mental fatigue), application (dietary supplements, functional foods and beverages, personal care or nutraceutical cosmetics, pharmaceuticals for clinical mental health use, sports nutrition, and others), distribution channel (direct sales to manufacturers, distributors and ingredient brokers, online B2B platforms, and others), and geography. The study also evaluates industry competitors and analyzes the market at the country level.
Based on ingredient type, the botanical extracts and adaptogens segment held the largest share of the mental care and nootropic ingredients market in 2025. This dominance comes from the growing consumer preference for natural and plant-based options for managing stress, improving cognitive function, and enhancing emotional well-being. Scientific support for traditional adaptogenic herbs like ashwagandha, rhodiola, ginseng, and lion's mane mushroom, along with the rising popularity of Ayurvedic and traditional medicine worldwide, also fuels this segment's growth. The clean-label trend and consumer preference for botanical ingredients over synthetic ones continue to increase demand. Ashwagandha makes up a significant portion of the adaptogenic ingredients market, with India producing about 85% of the global supply from over 14,000 hectares. These botanical ingredients provide proven benefits for stress management, cognitive improvement, and emotional balance, backed by both traditional use and modern clinical research. The growth of this segment reflects a major shift in consumer attitudes toward mental wellness, favoring natural, holistic solutions over pharmaceutical options.
Regarding function, the stress and anxiety relief segment held the largest share of the mental care and nootropic ingredients market in 2025. This dominance reflects the widespread effects of chronic stress on modern populations and the growing preference for natural, non-drug options for stress management. The World Health Organization reported that the COVID-19 pandemic caused a 25% increase in anxiety and depression cases worldwide, which significantly raised consumer interest in natural mental wellness solutions. Ingredients like ashwagandha, rhodiola rosea, L-theanine, GABA, and magnesium are commonly used in this segment. Clinical studies show they can help regulate cortisol levels and support healthy stress responses. The normalization of mental health discussions, driven by public health campaigns and celebrity advocacy, has lessened the stigma around stress management products. Modern lifestyle factors such as workplace pressures, academic demands, digital overload, and constant connectivity contribute to higher stress levels in all demographics. Consumers increasingly seek ingredients that provide calm without sedation, reduce anxiety with no side effects, and support emotional resilience during tough times.
In terms of application, the dietary supplements segment accounted for the largest share of the mental care and nootropic ingredients market in 2025. This dominance comes from the established supplement industry, high consumer awareness of cognitive health benefits, and the growing preference for easy-to-use, encapsulated formats that provide accurate dosing and standardized ingredient concentrations. The global dietary supplements market reached $133.77 billion in 2024 and is projected to grow at a rate of 4.9% each year through 2032, with brain health supplements being one of the fastest-growing categories. The increasing occurrence of cognitive health issues globally, especially among older populations aiming to maintain mental sharpness and prevent age-related cognitive decline, continues to drive demand. Supplement formats offer several benefits, including concentrated ingredient doses, precise standardization, convenience, long shelf life, and the ability to combine multiple synergistic ingredients in one formulation. The segment benefits from well-established distribution networks, including pharmacies, health food stores, e-commerce platforms, and direct-to-consumer sales. Consumer trust in supplement brands, supported by third-party testing, quality certifications, and clear labeling, further boosts market growth.
For distribution channels, the direct sales to manufacturers segment held the largest share of the mental care and nootropic ingredients market in 2025. This segment’s dominance stems from the reduction of intermediary costs, the ability to provide customized ingredient solutions that meet specific manufacturer needs, and the established relationships between major ingredient suppliers and large nutraceutical and pharmaceutical companies. The direct sales model offers significant benefits in customization and technical support, with ingredient suppliers collaborating directly with manufacturers to deliver tailored solutions, including custom particle sizes, specialized extraction methods, proprietary blends, and application-specific standardization levels. This channel fosters close cooperation on product development, allowing ingredient suppliers to understand manufacturers’ needs and provide formulation support, regulatory documentation, quality assurance, and technical expertise. Major dietary supplement manufacturers, functional food producers, and pharmaceutical firms prefer direct relationships with ingredient suppliers to ensure supply chain security, maintain quality control, access technical innovation, and negotiate better pricing. The direct sales model promotes transparency throughout the supply chain, from raw material sourcing to final ingredient delivery, which is increasingly essential for manufacturers responding to clean-label requirements.
A detailed geographic analysis of the industry provides both qualitative and quantitative insights into five major regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa, alongside key countries in each region. North America commanded the largest share of the overall mental care and nootropic ingredients market in 2025. This result is tied to high consumer awareness regarding cognitive health, a strong wellness culture, the presence of major market players, supportive regulations that ease product development and market access, and high consumer spending power. The United States leads the global nootropics market, supported by a robust health and wellness sector where around 60% of adults take dietary supplements. The region's well-developed retail infrastructure includes both physical stores with dedicated nootropic sections and sophisticated e-commerce platforms, ensuring a wide range of products are available across diverse demographic groups. North America's active biohacking culture and growing interest in cognitive enhancement among students, professionals, and entrepreneurs have expanded the consumer base beyond traditional supplement users. The region also benefits from advanced research institutions, clinical trial setups, and regulatory pathways that support ingredient innovation and product development.
Key Questions Answered in the Report–
What is the current revenue generated by the mental-care and nootropic ingredients market globally?
At what rate is the global mental-care and nootropic ingredients demand projected to grow for the next 5–10 years?
What are the historical market sizes and growth rates of the global mental-care and nootropic ingredients market?
What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
Which segments in terms of ingredient type, function, application, and distribution channel are expected to create major traction for the manufacturers in this market?
What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the manufacturers operating in the global mental-care and nootropic ingredients market?
Who are the major players in the global mental-care and nootropic ingredients market? What are their specific product offerings in this market?
What are the recent strategic developments in the global mental-care and nootropic ingredients market? What are the impacts of these strategic developments on the market?
Scope of the Report:
Mental-Care & Nootropic Ingredients Market Assessment – by Ingredient Type
Botanical Extracts/Adaptogens
Amino Acids
Vitamins & Minerals
Omega-3s and Lipids
Probiotics and Microbiome-Based Ingredients
Synthetic Nootropics
Others
Mental-Care & Nootropic Ingredients Market Assessment – by Function
Stress and Anxiety Relief
Mood Enhancement and Emotional Well-being
Cognitive Performance (Memory, Focus, Learning)
Neuroprotection and Brain Health
Sleep and Recovery
Energy & Mental Fatigue
Mental-Care & Nootropic Ingredients Market Assessment – by Application
Dietary Supplements
Functional Foods and Beverages
Personal Care/Nutraceutical Cosmetics
Pharmaceuticals for Clinical Mental Health Use
Sports Nutrition
Others
Mental-Care & Nootropic Ingredients Market Assessment – by Distribution Channel
Direct Sales to Manufacturers
Distributors and Ingredient Brokers
Online B2B Platforms
Others
Mental-Care & Nootropic Ingredients Market Assessment – by Geography
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Australia
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
Saudi Arabia
UAE
Rest of Middle East & Africa
Table of Contents
369 Pages
- 1. Introduction
- 1.1. Market Definition & Scope
- 1.2. Currency & Limitations
- 2 Research Methodology
- 2.1. Research Approach
- 2.2. Data Collection & Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research
- 2.3. Market Assessment
- 2.3.1. Market Size Estimation
- 2.3.2. Bottom-Up Approach
- 2.3.3. Top-Down Approach
- 2.3.4. Growth Forecast
- 2.4. Assumptions For the Study
- 3 Executive Summary
- 4 Market Insights
- 4.1. Overview
- 4.2. Drivers
- 4.2.1. Growing Prevalence of Mental Health Disorders and Stress-Related Conditions
- 4.2.2. Increasing Consumer Awareness of Cognitive Health and Preventive Mental Wellness
- 4.2.3. Rising Demand for Natural and Plant-Based Solutions
- 4.3. Restraints
- 4.3.1. Regulatory Variability and Claim Restrictions Across Markets
- 4.3.2. Limited Clinical Evidence for Some Emerging Ingredients
- 4.4. Opportunities
- 4.4.1. Expanding Clinical Validation and Regulatory Acceptance of Mental Wellness Claims
- 4.4.2. Growing Functional Beverage and Food Integration
- 4.5. Challenges
- 4.5.1. Quality Control and Standardization Issues
- 4.5.2. Supply Chain and Raw Material Sourcing Challenges
- 4.6. Trends
- 4.6.1. Gut-Brain Axis and Psychobiotic Innovation
- 4.6.2. Functional Beverage Expansion and Nootropic Coffee Alternatives
- 4.7. Porter's Five Forces Analysis
- 4.7.1. Threat Of New Entrants
- 4.7.2. Bargaining Power of Suppliers
- 4.7.3. Bargaining Power of Buyers
- 4.7.4. Threat Of Substitute Products
- 4.7.5. Competitive Rivalry
- 5 The Impact of Ingredient Innovation and Technology on The Global Mental-Care & Nootropic Ingredients Market
- 5.1. Introduction To Ingredient Innovation and Bioavailability Enhancement
- 5.2. Advanced Extraction and Standardization Technologies
- 5.3. Bioavailability Enhancement and Delivery System Innovation
- 5.4. Clinical Validation and Evidence-Based Ingredient Development
- 5.5. Sustainable Sourcing and Vertical Integration Strategies
- 5.6. Proprietary Ingredient Development and Branded Ingredients
- 5.7. Quality Control and Analytical Testing Advancements
- 5.8. Impact On Market Growth and Competitive Differentiation
- 6 Global Mental-Care & Nootropic Ingredients Market, By Ingredient Type
- 6.1. Overview
- 6.2. Botanical Extracts / Adaptogens
- 6.2.1. Ashwagandha
- 6.2.2. Rhodiola
- 6.2.3. Ginseng
- 6.2.4. Lion's Mane & Other Mushroom Extracts
- 6.2.5. Bacopa Monnieri
- 6.2.6. Holy Basil (Tulsi)
- 6.2.7. Ginkgo Biloba
- 6.2.8. Others (Passionflower, Lemon Balm, Valerian Root)
- 6.3. Amino Acids
- 6.3.1. L-Theanine
- 6.3.2. Gaba (Gamma-Aminobutyric Acid)
- 6.3.3. L-Tyrosine
- 6.3.4. 5-Htp (5-Hydroxytryptophan)
- 6.3.5. Others
- 6.4. Vitamins & Minerals
- 6.4.1. B-Vitamins
- 6.4.2. Magnesium
- 6.4.3. Zinc
- 6.4.4. Vitamin D
- 6.4.5. Others
- 6.5. Omega-3 / Lipids
- 6.5.1. Dha (Docosahexaenoic Acid)
- 6.5.1.1. Fish-Derived Dha
- 6.5.1.2. Algal Dha
- 6.5.2. Epa (Eicosapentaenoic Acid)
- 6.5.3. Phospholipids (Phosphatidylserine, Phosphatidylcholine)
- 6.6. Probiotics / Microbiome-Based
- 6.6.1. Lactobacillus Strains
- 6.6.2. Bifidobacterium Strains
- 6.6.3. Multi-Strain Psychobiotic Formulations
- 6.6.4. Prebiotics And Postbiotics
- 6.7. Synthetic Nootropics
- 6.7.1. Citicoline (Cdp-Choline)
- 6.7.2. Alpha-Gpc (Alpha-Glycerylphosphorylcholine)
- 6.7.3. Others
- 6.8. Others
- 7 Global Mental-Care & Nootropic Ingredients Market, By Function
- 7.1. Overview
- 7.2. Stress / Anxiety Relief
- 7.3. Mood Enhancement / Emotional Well-Being
- 7.4. Cognitive Performance (Memory, Focus, Learning)
- 7.5. Neuroprotection / Brain Health
- 7.6. Sleep / Recovery
- 7.7. Energy & Mental Fatigue
- 8 Global Mental-Care & Nootropic Ingredients Market, By Application
- 8.1. Overview
- 8.2. Dietary Supplements
- 8.3. Functional Foods & Beverages
- 8.4. Personal Care / Nutraceutical Cosmetics
- 8.5. Pharmaceuticals / Clinical Mental Health Use
- 8.6. Sports Nutrition
- 8.7. Others
- 9 Global Mental-Care & Nootropic Ingredients Market, By Distribution Channel
- 9.1. Overview
- 9.2. Direct Sales to Manufacturers
- 9.3. Distributors And Ingredient Brokers
- 9.4. Online B2b Platforms
- 9.5. Others
- 10 Mental-Care & Nootropic Ingredients Market Assessment, By Geography
- 10.1. Overview
- 10.2. North America
- 10.2.1. U.S.
- 10.2.2. Canada
- 10.3. Europe
- 10.3.1. Germany
- 10.3.2. U.K.
- 10.3.3. France
- 10.3.4. Italy
- 10.3.5. Spain
- 10.3.6. Switzerland
- 10.3.7. Rest Of Europe
- 10.4. Asia-Pacific
- 10.4.1. China
- 10.4.2. Japan
- 10.4.3. India
- 10.4.4. South Korea
- 10.4.5. Australia
- 10.4.6. Indonesia
- 10.4.7. Thailand
- 10.4.8. Singapore
- 10.4.9. Vietnam
- 10.4.10. Philippines
- 10.4.11. Rest Of Asia-Pacific
- 10.5. Latin America
- 10.5.1. Brazil
- 10.5.2. Mexico
- 10.5.3. Argentina
- 10.5.4. Rest Of Latin America
- 10.6. Middle East & Africa
- 10.6.1. Saudi Arabia
- 10.6.2. UAE
- 10.6.3. South Africa
- 10.6.4. Rest Of Middle East & Africa
- 11 Competitive Landscape
- 11.1. Introduction
- 11.2. Key Growth Strategies
- 11.3. Competitive Benchmarking
- 11.4. Competitive Dashboard
- 11.4.1. Industry Leaders
- 11.4.2. Market Differentiators
- 11.4.3. Vanguards
- 11.4.4. Emerging Companies
- 11.5. Market Share/Position Analysis
- 12 Company Profiles
- 12.1. Sabinsa Corporation
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio
- 12.1.3. Strategic Developments
- 12.2. Arjuna Natural Pvt. Ltd.
- 12.2.1. Company Overview
- 12.2.2. Product Portfolio
- 12.3. Ixoreal Biomed Inc. (Ksm‑66 Ashwagandha)
- 12.3.1. Company Overview
- 12.3.2. Product Portfolio
- 12.3.3. Strategic Developments
- 12.4. Natreon Inc.
- 12.4.1. Company Overview
- 12.4.2. Product Portfolio
- 12.5. Verdure Sciences (Lonza - Capsules & Health Ingredients)
- 12.5.1. Company Overview
- 12.5.2. Product Portfolio
- 12.6. Kyowa Hakko Bio Co. Ltd.
- 12.6.1. Company Overview
- 12.6.2. Product Portfolio
- 12.6.3. Strategic Developments
- 12.7. Chr. Hansen Holding A/S (Novonesis)
- 12.7.1. Company Overview
- 12.7.2. Product Portfolio
- 12.8. Dsm‑Firmenich (Royal Dsm)
- 12.8.1. Company Overview
- 12.8.2. Product Portfolio
- 12.9. Nammex
- 12.9.1. Company Overview
- 12.9.2. Product Portfolio
- 12.10. Pharmachem Laboratories
- 12.10.1. Company Overview
- 12.10.2. Product Portfolio
- 12.11. Organic Herb Inc.
- 12.11.1. Company Overview
- 12.11.2. Product Portfolio
- 12.12. Daesang Corporation
- 12.12.1. Company Overview
- 12.12.2. Financial Overview
- 12.12.3. Product Portfolio
- 12.13. Nexira
- 12.13.1. Company Overview
- 12.13.2. Product Portfolio
- 12.13.3. Strategic Developments
- 12.14. Glanbia Nutritionals (Glanbia Plc)
- 12.14.1. Company Overview
- 12.14.2. Financial Overview
- 12.14.3. Product Portfolio
- 12.15. Roquette Frères
- 12.15.1. Company Overview
- 12.15.2. Product Portfolio
- 13 Appendix
- 13.1. Available Customization
- 13.2. Related Reports
- Table 1 Global Mental-Care & Nootropic Ingredients Market, By Type, 2025-2035 (USD Million)
- Table 2 Global Botanical Extracts Market, By Type, 2025-2035 (USD Million)
- Table 3 Global Botanical Extracts Market, By Country/Region, 2023-2035 (USD Million)
- Table 4 Global Ashwagandha Market, By Country/Region, 2023-2035 (USD Million)
- Table 5 Global Rhodiola Market, By Country/Region, 2023-2035 (USD Million)
- Table 6 Global Ginseng Market, By Country/Region, 2023-2035 (USD Million)
- Table 7 Global Lion’s Mane & Other Mushrooms Extracts Market, By Country/Region, 2023-2035 (USD Million)
- Table 8 Global Bacopa Monnieri Market, By Country/Region, 2023-2035 (USD Million)
- Table 9 Global Holy Basil (Tulsi) Market, By Country/Region, 2023-2035 (USD Million)
- Table 10 Global Ginkgo Biloba Market, By Country/Region, 2023-2035 (USD Million)
- Table 11 Global Others Botanical Extracts Market, By Country/Region, 2023-2035 (USD Million)
- Table 12 Global Amino Acids Market, By Type, 2025-2035 (USD Million)
- Table 13 Global Amino Acids Market, By Country/Region, 2023-2035 (USD Million)
- Table 14 Global Amino Acids Market, By Country/Region, 2023-2035 (Metric Tons)
- Table 15 Global L-Theanine Market, By Country/Region, 2023-2035 (USD Million)
- Table 16 Global L-Theanine Market, By Country/Region, 2023-2035 (Metric Tons)
- Table 17 Global Gaba Market, By Country/Region, 2023-2035 (USD Million)
- Table 18 Global L-Tyrosine Market, By Country/Region, 2023-2035 (USD Million)
- Table 19 Global 5-Htp Market, By Country/Region, 2023-2035 (USD Million)
- Table 20 Global Others Amino Acids Market, By Country/Region, 2023-2035 (USD Million)
- Table 21 Global Vitamins & Minerals Market, By Type, 2025-2035 (USD Million)
- Table 22 Global Vitamins & Minerals Market, By Country/Region, 2023-2035 (USD Million)
- Table 23 Global B-Vitamins Market, By Country/Region, 2023-2035 (USD Million)
- Table 24 Global Magnesium Market, By Country/Region, 2023-2035 (USD Million)
- Table 25 Global Zinc Market, By Country/Region, 2023-2035 (USD Million)
- Table 26 Global Vitamin D Market, By Country/Region, 2023-2035 (USD Million)
- Table 27 Global Other Vitamins And Minerals Market, By Country/Region, 2023-2035 (USD Million)
- Table 28 Global Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 29 Global Omega-3 Market, By Country/Region, 2023-2035 (USD Million)
- Table 30 Global Dha (Docosahexaenoic Acid) Market, By Type, 2025-2035 (USD Million)
- Table 31 Global Dha (Docosahexaenoic Acid) Market, By Country/Region, 2023-2035 (USD Million)
- Table 32 Global Fish-Derived Dha Market, By Country/Region, 2023-2035 (USD Million)
- Table 33 Global Algal Dha Market, By Country/Region, 2023-2035 (USD Million)
- Table 34 Global Epa Market, By Country/Region, 2023-2035 (USD Million)
- Table 35 Global Phospholipids (Ps, Pc) Market, By Country/Region, 2023-2035 (USD Million)
- Table 36 Global Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 37 Global Probiotics / Microbiome-Based Market, By Country/Region, 2023-2035 (USD Million)
- Table 38 Global Lactobacillus Strains Market, By Country/Region, 2023-2035 (USD Million)
- Table 39 Global Bifidobacterium Strains Market, By Country/Region, 2023-2035 (USD Million)
- Table 40 Global Multi-Strain Psychobiotics Market, By Country/Region, 2023-2035 (USD Million)
- Table 41 Global Prebiotics & Postbiotics Market, By Country/Region, 2023-2035 (USD Million)
- Table 42 Global Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 43 Global Synthetic Nootropics Market, By Country/Region, 2023-2035 (USD Million)
- Table 44 Global Citicoline (Cdp-Choline) Market, By Country/Region, 2023-2035 (USD Million)
- Table 45 Global Alpha-Gpc Market, By Country/Region, 2023-2035 (USD Million)
- Table 46 Global Others Synthetic Nootropics Market, By Country/Region, 2023-2035 (USD Million)
- Table 47 Global Others Mental-Care & Nootropic Ingredients Market, By Country/Region, 2023-2035 (USD Million)
- Table 48 Global Mental-Care & Nootropic Ingredients Market, By Function, 2025-2035 (USD Million)
- Table 49 Global Mental-Care & Nootropic Ingredients Market for Stress / Anxiety Relief, By Country/Region, 2023-2035 (USD Million)
- Table 50 Global Mental-Care & Nootropic Ingredients Market for Mood Enhancement / Emotional Well-Being, By Country/Region, 2023-2035 (USD Million)
- Table 51 Global Mental-Care & Nootropic Ingredients Market for Cognitive Performance (Memory, Focus, Learning), By Country/Region, 2023-2035 (USD Million)
- Table 52 Global Mental-Care & Nootropic Ingredients Market for Neuroprotection / Brain Health, By Country/Region, 2023-2035 (USD Million)
- Table 53 Global Mental-Care & Nootropic Ingredients Market for Sleep / Recovery, By Country/Region, 2023-2035 (USD Million)
- Table 54 Global Mental-Care & Nootropic Ingredients Market for Energy & Mental Fatigue, By Country/Region, 2023-2035 (USD Million)
- Table 55 Global Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 56 Global Mental-Care & Nootropic Ingredients Market for Dietary Supplements, By Country/Region, 2023-2035 (USD Million)
- Table 57 Global Mental-Care & Nootropic Ingredients Market for Functional Foods & Beverages, By Country/Region, 2023-2035 (USD Million)
- Table 58 Global Mental-Care & Nootropic Ingredients Market for Personal Care / Nutraceutical Cosmetics, By Country/Region, 2023-2035 (USD Million)
- Table 59 Global Mental-Care & Nootropic Ingredients Market for Pharmaceuticals / Clinical Mental Health Use, By Country/Region, 2023-2035 (USD Million)
- Table 60 Global Mental-Care & Nootropic Ingredients Market for Sports Nutrition, By Country/Region, 2023-2035 (USD Million)
- Table 61 Global Mental-Care & Nootropic Ingredients Market for Others Application, By Country/Region, 2023-2035 (USD Million)
- Table 62 Global Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 63 Global Mental-Care & Nootropic Ingredients Market for Direct Sales to Manufacturers, By Country/Region, 2023-2035 (USD Million)
- Table 64 Global Mental-Care & Nootropic Ingredients Market for Distributors & Ingredient Brokers, By Country/Region, 2023-2035 (USD Million)
- Table 65 Global Mental-Care & Nootropic Ingredients Market for Online B2b Platforms, By Country/Region, 2023-2035 (USD Million)
- Table 66 Global Mental-Care & Nootropic Ingredients Market for Other Channels, By Country/Region, 2023-2035 (USD Million)
- Table 67 North America: Mental-Care & Nootropic Ingredients Market, By Country, 2023–2035 (USD Million)
- Table 68 North America: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
- Table 69 North America: Botanical Extracts Market, By Type, 2023-2035 (USD Million)
- Table 70 North America: Vitamins & Minerals Market, By Type, 2023-2035 (USD Million)
- Table 71 North America: Amino Acids Market, By Type, 2023-2035 (USD Million)
- Table 72 North America: Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 73 North America: Dha (Docosahexaenoic Acid) Market, By Type, 2025–2035 (USD Million)
- Table 74 North America: Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 75 North America: Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 76 North America: Mental-Care & Nootropic Ingredients Market, By Function, 2025–2035 (USD Million)
- Table 77 North America: Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 78 North America: Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 79 U.S.: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
- Table 80 U.S.: Botanical Extracts Market, By Type, 2023-2035 (USD Million)
- Table 81 U.S.: Vitamins & Minerals Market, By Type, 2023-2035 (USD Million)
- Table 82 U.S.: Amino Acids Market, By Type, 2023-2035 (USD Million)
- Table 83 U.S.: Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 84 U.S.: Dha (Docosahexaenoic Acid) Market, By Type, 2025–2035 (USD Million)
- Table 85 U.S.: Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 86 U.S.: Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 87 U.S.: Mental-Care & Nootropic Ingredients Market, By Function, 2025–2035 (USD Million)
- Table 88 U.S.: Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 89 U.S.: Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 90 Canada: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
- Table 91 Canada: Botanical Extracts Market, By Type, 2023-2035 (USD Million)
- Table 92 Canada: Vitamins & Minerals Market, By Type, 2023-2035 (USD Million)
- Table 93 Canada: Amino Acids Market, By Type, 2023-2035 (USD Million)
- Table 94 Canada: Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 95 Canada: Dha (Docosahexaenoic Acid) Market, By Type, 2025–2035 (USD Million)
- Table 96 Canada: Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 97 Canada: Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 98 Canada: Mental-Care & Nootropic Ingredients Market, By Function, 2025–2035 (USD Million)
- Table 99 Canada: Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 100 Canada: Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 101 Europe: Mental-Care & Nootropic Ingredients Market, By Country, 2023-2035 (USD Million)
- Table 102 Europe: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
- Table 103 Europe: Botanical Extracts Market, By Type, 2023-2035 (USD Million)
- Table 104 Europe: Vitamins & Minerals Market, By Type, 2023-2035 (USD Million)
- Table 105 Europe: Amino Acids Market, By Type, 2023-2035 (USD Million)
- Table 106 Europe: Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 107 Europe: Dha (Docosahexaenoic Acid) Market, By Type, 2025–2035 (USD Million)
- Table 108 Europe: Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 109 Europe: Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 110 Europe: Mental-Care & Nootropic Ingredients Market, By Function, 2025–2035 (USD Million)
- Table 111 Europe: Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 112 Europe: Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 113 Germany: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
- Table 114 Germany: Botanical Extracts Market, By Type, 2023-2035 (USD Million)
- Table 115 Germany: Vitamins & Minerals Market, By Type, 2023-2035 (USD Million)
- Table 116 Germany: Amino Acids Market, By Type, 2023-2035 (USD Million)
- Table 117 Germany: Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 118 Germany: Dha (Docosahexaenoic Acid) Market, By Type, 2025–2035 (USD Million)
- Table 119 Germany: Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 120 Germany: Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 121 Germany: Mental-Care & Nootropic Ingredients Market, By Function, 2025–2035 (USD Million)
- Table 122 Germany: Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 123 Germany: Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 124 U.K.: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
- Table 125 U.K.: Botanical Extracts Market, By Type, 2023-2035 (USD Million)
- Table 126 U.K.: Vitamins & Minerals Market, By Type, 2023-2035 (USD Million)
- Table 127 U.K.: Amino Acids Market, By Type, 2023-2035 (USD Million)
- Table 128 U.K.: Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 129 U.K.: Dha (Docosahexaenoic Acid) Market, By Type, 2025–2035 (USD Million)
- Table 130 U.K.: Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 131 U.K.: Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 132 U.K.: Mental-Care & Nootropic Ingredients Market, By Function, 2025–2035 (USD Million)
- Table 133 U.K.: Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 134 U.K.: Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 135 France: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
- Table 136 France: Botanical Extracts Market, By Type, 2023-2035 (USD Million)
- Table 137 France: Vitamins & Minerals Market, By Type, 2023-2035 (USD Million)
- Table 138 France: Amino Acids Market, By Type, 2023-2035 (USD Million)
- Table 139 France: Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 140 France: Dha (Docosahexaenoic Acid) Market, By Type, 2025–2035 (USD Million)
- Table 141 France: Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 142 France: Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 143 France: Mental-Care & Nootropic Ingredients Market, By Function, 2025–2035 (USD Million)
- Table 144 France: Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 145 France: Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 146 Italy: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
- Table 147 Italy: Botanical Extracts Market, By Type, 2023-2035 (USD Million)
- Table 148 Italy: Vitamins & Minerals Market, By Type, 2023-2035 (USD Million)
- Table 149 Italy: Amino Acids Market, By Type, 2023-2035 (USD Million)
- Table 150 Italy: Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 151 Italy: Dha (Docosahexaenoic Acid) Market, By Type, 2025–2035 (USD Million)
- Table 152 Italy: Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 153 Italy: Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 154 Italy: Mental-Care & Nootropic Ingredients Market, By Function, 2025–2035 (USD Million)
- Table 155 Italy: Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 156 Italy: Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 157 Spain: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
- Table 158 Spain: Botanical Extracts Market, By Type, 2023-2035 (USD Million)
- Table 159 Spain: Vitamins & Minerals Market, By Type, 2023-2035 (USD Million)
- Table 160 Spain: Amino Acids Market, By Type, 2023-2035 (USD Million)
- Table 161 Spain: Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 162 Spain: Dha (Docosahexaenoic Acid) Market, By Type, 2025–2035 (USD Million)
- Table 163 Spain: Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 164 Spain: Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 165 Spain: Mental-Care & Nootropic Ingredients Market, By Function, 2025–2035 (USD Million)
- Table 166 Spain: Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 167 Spain: Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 168 Switzerland: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
- Table 169 Switzerland: Botanical Extracts Market, By Type, 2023-2035 (USD Million)
- Table 170 Switzerland: Vitamins & Minerals Market, By Type, 2023-2035 (USD Million)
- Table 171 Switzerland: Amino Acids Market, By Type, 2023-2035 (USD Million)
- Table 172 Switzerland: Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 173 Switzerland: Dha (Docosahexaenoic Acid) Market, By Type, 2025–2035 (USD Million)
- Table 174 Switzerland: Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 175 Switzerland: Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 176 Switzerland: Mental-Care & Nootropic Ingredients Market, By Function, 2025–2035 (USD Million)
- Table 177 Switzerland: Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 178 Switzerland: Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 179 Rest of Europe: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
- Table 180 Rest of Europe: Botanical Extracts Market, By Type, 2023-2035 (USD Million)
- Table 181 Rest of Europe: Vitamins & Minerals Market, By Type, 2023-2035 (USD Million)
- Table 182 Rest of Europe: Amino Acids Market, By Type, 2023-2035 (USD Million)
- Table 183 Rest of Europe: Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 184 Rest of Europe: Dha (Docosahexaenoic Acid) Market, By Type, 2025–2035 (USD Million)
- Table 185 Rest of Europe: Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 186 Rest of Europe: Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 187 Rest of Europe: Mental-Care & Nootropic Ingredients Market, By Function, 2025–2035 (USD Million)
- Table 188 Rest of Europe: Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 189 Rest of Europe: Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 190 Asia-Pacific: Mental-Care & Nootropic Ingredients Market, By Country, 2023–2035 (USD Million)
- Table 191 Asia-Pacific: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
- Table 192 Asia-Pacific: Botanical Extracts Market, By Type, 2023-2035 (USD Million)
- Table 193 Asia-Pacific: Vitamins & Minerals Market, By Type, 2023-2035 (USD Million)
- Table 194 Asia-Pacific: Amino Acids Market, By Type, 2023-2035 (USD Million)
- Table 195 Asia-Pacific: Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 196 Asia-Pacific: Dha (Docosahexaenoic Acid) Market, By Type, 2025–2035 (USD Million)
- Table 197 Asia-Pacific: Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 198 Asia-Pacific: Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 199 Asia-Pacific: Mental-Care & Nootropic Ingredients Market, By Function, 2025–2035 (USD Million)
- Table 200 Asia-Pacific: Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 201 Asia-Pacific: Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 202 China: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
- Table 203 China: Botanical Extracts Market, By Type, 2023-2035 (USD Million)
- Table 204 China: Vitamins & Minerals Market, By Type, 2023-2035 (USD Million)
- Table 205 China: Amino Acids Market, By Type, 2023-2035 (USD Million)
- Table 206 China: Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 207 China: Dha (Docosahexaenoic Acid) Market, By Type, 2025–2035 (USD Million)
- Table 208 China: Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 209 China: Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 210 China: Mental-Care & Nootropic Ingredients Market, By Function, 2025–2035 (USD Million)
- Table 211 China: Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 212 China: Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 213 Japan: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
- Table 214 Japan: Botanical Extracts Market, By Type, 2023-2035 (USD Million)
- Table 215 Japan: Vitamins & Minerals Market, By Type, 2023-2035 (USD Million)
- Table 216 Japan: Amino Acids Market, By Type, 2023-2035 (USD Million)
- Table 217 Japan: Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 218 Japan: Dha (Docosahexaenoic Acid) Market, By Type, 2025–2035 (USD Million)
- Table 219 Japan: Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 220 Japan: Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 221 Japan: Mental-Care & Nootropic Ingredients Market, By Function, 2025–2035 (USD Million)
- Table 222 Japan: Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 223 Japan: Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 224 India: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
- Table 225 India: Botanical Extracts Market, By Type, 2023-2035 (USD Million)
- Table 226 India: Vitamins & Minerals Market, By Type, 2023-2035 (USD Million)
- Table 227 India: Amino Acids Market, By Type, 2023-2035 (USD Million)
- Table 228 India: Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 229 India: Dha (Docosahexaenoic Acid) Market, By Type, 2025–2035 (USD Million)
- Table 230 India: Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 231 India: Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 232 India: Mental-Care & Nootropic Ingredients Market, By Function, 2025–2035 (USD Million)
- Table 233 India: Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 234 India: Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 235 South Korea: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
- Table 236 South Korea: Botanical Extracts Market, By Type, 2023-2035 (USD Million)
- Table 237 South Korea: Vitamins & Minerals Market, By Type, 2023-2035 (USD Million)
- Table 238 South Korea: Amino Acids Market, By Type, 2023-2035 (USD Million)
- Table 239 South Korea: Omega-3 Market, By Type, 2025-2035 (USD Million)
- Table 240 South Korea: Dha (Docosahexaenoic Acid) Market, By Type, 2025–2035 (USD Million)
- Table 241 South Korea: Probiotics / Microbiome-Based Ingredients, By Type, 2025-2035 (USD Million)
- Table 242 South Korea: Synthetic Nootropics Market, By Type, 2025-2035 (USD Million)
- Table 243 South Korea: Mental-Care & Nootropic Ingredients Market, By Function, 2025–2035 (USD Million)
- Table 244 South Korea: Mental-Care & Nootropic Ingredients Market, By Application, 2025–2035 (USD Million)
- Table 245 South Korea: Mental-Care & Nootropic Ingredients Market, By Distribution Channel, 2025–2035 (USD Million)
- Table 246 Australia: Mental-Care & Nootropic Ingredients Market, By Ingredient Type, 2023-2035 (USD Million)
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.